Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Development and binding mode assessment of N-[4-[2-propyn-1-yl[(6S)-4
Brinzolamide is a carbonic anhydrase inhibitor used to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension
H2O/c1-31(2)24(36)13-4-6-15(27-20(33)21(34)30-19-7-5-14(25)11-26-19)17(10-13)28-22(35)23-29-16-8-9-32(3)12-18(16)37-23
Formula: C26H27NO5
12-bis(acetyloxy)-1-hydroxy-15-{[(2R
CHM-1 icalcitol Development and binding mode assessmentCHM 1, a microtubule destabilizing agent, inhibits tubulin polymerization. CHM 1 is a potent and selective antimitotic antitumor activity against human hepatocellular carcinoma. CHM 1 induces growth inhibition and apoptosis via G2 M phase arrest in human hepatocellular carcinoma cells by activation of Cdc2 kinase activity. Product information CAS Number: 154554 41 3 Molecular Weight: 283. 25 Formula: C16H10FNO3 Chemical Name: 6 (2 fluorophenyl)
US$ 230.50
US$ 137.00
US$ 31.00
US$ 165.00
US$ 19.50
US$ 29.00
US$ 155.00